The cases, observed mostly in young men who had received the Pfizer/BioNTech jab, have a ‘probable link’ to the second dose of the vaccine, according to Israel.
Israel’s Health Ministry reported that it was aware of 275 cases of myocarditis occurring between December 2020 to May 2021, with 148 of these cases happening within a short time frame after receiving the Pfizer/BioNTech vaccine.
The ministry added that the majority were seen among men under the age of 30 years and particularly in those aged between 16 and 19 years old.
Of the 5,401,150 who had been given the vaccine within this time period, 27 myocarditis cases were reported, including in 11 people with pre-existing conditions, shortly after their first Pfizer/BioNTech vaccine dose.
This increased after the second dose, however, with 121 cases, including 60 people with pre-existing conditions, developing myocarditis within 30 days out of a total 5,049,424 fully vaccinated individuals in Israel…